Danaher (NYSE:DHR) is a global science and technology innovator headquartered in Washington, D.C., that designs, manufactures and markets products and services to professional, medical, industrial and commercial customers. The company operates through three core segments: Life Sciences, Diagnostics and Environmental & Applied Solutions. Its Life Sciences segment provides critical tools and instruments for research, bioprocessing, drug discovery and genomic analysis, featuring well-known brands such as Cytiva, Beckman Coulter Life Sciences and Leica Microsystems.
The Diagnostics segment offers a portfolio of systems and consumables for clinical diagnostics, molecular diagnostics, pathology and genetics testing. This includes products from Cepheid, Beckman Coulter Diagnostics and Radiometer. Meanwhile, the Environmental & Applied Solutions segment delivers instrumentation, consumables and software for water quality analysis, chemical processing, product identification and product inspection, with leading brands such as Hach, Pall Corporation and Videojet Technologies.
Originally founded in 1969 as Diversified Tool & Die, the company adopted the Danaher name following a strategic realignment in the early 1980s. Over more than five decades, Danaher has pursued a disciplined acquisition strategy to expand its capabilities, integrating over 200 businesses into its platform. Today, the company serves customers in more than 60 countries, leveraging a global network of research and manufacturing facilities to address complex challenges in health care, environmental sustainability and industrial productivity.
Danaher is led by an executive management team overseen by Chief Executive Officer Rainer Blair and a Board of Directors that emphasizes continuous improvement through its proprietary Danaher Business System. With a focus on innovation and operational excellence, the company aims to advance science and technology while delivering solutions that enhance quality of life worldwide.
